Bipolar Disorder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Bipolar disorder (formerly called manic-depressive illness or manic depression) is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks.

The global market for Bipolar Disorder was estimated to be worth US$ 5781 million in 2023 and is forecast to a readjusted size of US$ 6994.7 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030

Bipolar Disorder Market Size

M= millions and B=billions

North American market for Bipolar Disorder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bipolar Disorder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Bipolar Disorder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Bipolar Disorder include Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Ltd and AstraZeneca, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bipolar Disorder by region & country, by Type, and by Application.

The Bipolar Disorder market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder.

Market Segmentation

• Report Metric

• Details

• Report Title

• Bipolar Disorder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Forecasted Market Size in 2030

• US$ 6994.7 million

• CAGR(2024-2030)

• 2.7%

• Market Size Available for Years

• 2019-2030

• Global Bipolar Disorder Companies Covered

• Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Ltd, AstraZeneca

• Global Bipolar Disorder Market, by Region

• North America (U.S., Canada, Mexico)

  Europe (Germany, France, UK, Italy, etc.)

  Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

  South America (Brazil, etc.)

  Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

• Global Bipolar Disorder Market, Segment by Type

• Bipolar I Disorder

  Bipolar II Disorder

  Cyclothymic Disorder

• Global Bipolar Disorder Market, Segment by Application

• Mood Stabilizers

  Anticonvulsants

  Antipsychotic drugs

  Antidepressant drugs

  Antianxiety drugs

  Others

• Forecast Units

• USD million in value

• Report Coverage

• Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bipolar Disorder manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Bipolar Disorder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Bipolar Disorder in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Bipolar Disorder Product Introduction
    1.2 Global Bipolar Disorder Market Size Forecast
    1.3 Bipolar Disorder Market Trends & Drivers
        1.3.1 Bipolar Disorder Industry Trends
        1.3.2 Bipolar Disorder Market Drivers & Opportunity
        1.3.3 Bipolar Disorder Market Challenges
        1.3.4 Bipolar Disorder Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Bipolar Disorder Players Revenue Ranking (2023)
    2.2 Global Bipolar Disorder Revenue by Company (2019-2024)
    2.3 Key Companies Bipolar Disorder Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Bipolar Disorder Product Offered
    2.5 Key Companies Time to Begin Mass Production of Bipolar Disorder
    2.6 Bipolar Disorder Market Competitive Analysis
        2.6.1 Bipolar Disorder Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Bipolar Disorder Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Bipolar I Disorder
        3.1.2 Bipolar II Disorder
        3.1.3 Cyclothymic Disorder
    3.2 Global Bipolar Disorder Sales Value by Type
        3.2.1 Global Bipolar Disorder Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Bipolar Disorder Sales Value, by Type (2019-2030)
        3.2.3 Global Bipolar Disorder Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Mood Stabilizers
        4.1.2 Anticonvulsants
        4.1.3 Antipsychotic drugs
        4.1.4 Antidepressant drugs
        4.1.5 Antianxiety drugs
        4.1.6 Others
    4.2 Global Bipolar Disorder Sales Value by Application
        4.2.1 Global Bipolar Disorder Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Bipolar Disorder Sales Value, by Application (2019-2030)
        4.2.3 Global Bipolar Disorder Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Bipolar Disorder Sales Value by Region
        5.1.1 Global Bipolar Disorder Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Bipolar Disorder Sales Value by Region (2019-2024)
        5.1.3 Global Bipolar Disorder Sales Value by Region (2025-2030)
        5.1.4 Global Bipolar Disorder Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Bipolar Disorder Sales Value, 2019-2030
        5.2.2 North America Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Bipolar Disorder Sales Value, 2019-2030
        5.3.2 Europe Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Bipolar Disorder Sales Value, 2019-2030
        5.4.2 Asia Pacific Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Bipolar Disorder Sales Value, 2019-2030
        5.5.2 South America Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Bipolar Disorder Sales Value, 2019-2030
        5.6.2 Middle East & Africa Bipolar Disorder Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Bipolar Disorder Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Bipolar Disorder Sales Value
    6.3 United States
        6.3.1 United States Bipolar Disorder Sales Value, 2019-2030
        6.3.2 United States Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Bipolar Disorder Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Bipolar Disorder Sales Value, 2019-2030
        6.4.2 Europe Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Bipolar Disorder Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Bipolar Disorder Sales Value, 2019-2030
        6.5.2 China Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Bipolar Disorder Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Bipolar Disorder Sales Value, 2019-2030
        6.6.2 Japan Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Bipolar Disorder Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Bipolar Disorder Sales Value, 2019-2030
        6.7.2 South Korea Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Bipolar Disorder Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Bipolar Disorder Sales Value, 2019-2030
        6.8.2 Southeast Asia Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Bipolar Disorder Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Bipolar Disorder Sales Value, 2019-2030
        6.9.2 India Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Bipolar Disorder Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Glaxo SmithKline (GSK)
        7.1.1 Glaxo SmithKline (GSK) Profile
        7.1.2 Glaxo SmithKline (GSK) Main Business
        7.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Products, Services and Solutions
        7.1.4 Glaxo SmithKline (GSK) Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.1.5 Glaxo SmithKline (GSK) Recent Developments
    7.2 Pfizer Inc.
        7.2.1 Pfizer Inc. Profile
        7.2.2 Pfizer Inc. Main Business
        7.2.3 Pfizer Inc. Bipolar Disorder Products, Services and Solutions
        7.2.4 Pfizer Inc. Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.2.5 Pfizer Inc. Recent Developments
    7.3 Janssen Pharmaceuticals
        7.3.1 Janssen Pharmaceuticals Profile
        7.3.2 Janssen Pharmaceuticals Main Business
        7.3.3 Janssen Pharmaceuticals Bipolar Disorder Products, Services and Solutions
        7.3.4 Janssen Pharmaceuticals Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.3.5 Eli Lilly Recent Developments
    7.4 Eli Lilly
        7.4.1 Eli Lilly Profile
        7.4.2 Eli Lilly Main Business
        7.4.3 Eli Lilly Bipolar Disorder Products, Services and Solutions
        7.4.4 Eli Lilly Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.4.5 Eli Lilly Recent Developments
    7.5 Allergan Plc.
        7.5.1 Allergan Plc. Profile
        7.5.2 Allergan Plc. Main Business
        7.5.3 Allergan Plc. Bipolar Disorder Products, Services and Solutions
        7.5.4 Allergan Plc. Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.5.5 Allergan Plc. Recent Developments
    7.6 Novartis AG
        7.6.1 Novartis AG Profile
        7.6.2 Novartis AG Main Business
        7.6.3 Novartis AG Bipolar Disorder Products, Services and Solutions
        7.6.4 Novartis AG Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.6.5 Novartis AG Recent Developments
    7.7 AbbVie Inc.
        7.7.1 AbbVie Inc. Profile
        7.7.2 AbbVie Inc. Main Business
        7.7.3 AbbVie Inc. Bipolar Disorder Products, Services and Solutions
        7.7.4 AbbVie Inc. Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.7.5 AbbVie Inc. Recent Developments
    7.8 Otsuka Holdings Ltd
        7.8.1 Otsuka Holdings Ltd Profile
        7.8.2 Otsuka Holdings Ltd Main Business
        7.8.3 Otsuka Holdings Ltd Bipolar Disorder Products, Services and Solutions
        7.8.4 Otsuka Holdings Ltd Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.8.5 Otsuka Holdings Ltd Recent Developments
    7.9 AstraZeneca
        7.9.1 AstraZeneca Profile
        7.9.2 AstraZeneca Main Business
        7.9.3 AstraZeneca Bipolar Disorder Products, Services and Solutions
        7.9.4 AstraZeneca Bipolar Disorder Revenue (US$ Million) & (2019-2024)
        7.9.5 AstraZeneca Recent Developments

 8 Industry Chain Analysis
    8.1 Bipolar Disorder Industrial Chain
    8.2 Bipolar Disorder Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Bipolar Disorder Sales Model
        8.5.2 Sales Channel
        8.5.3 Bipolar Disorder Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Bipolar Disorder Market Trends
    Table 2. Bipolar Disorder Market Drivers & Opportunity
    Table 3. Bipolar Disorder Market Challenges
    Table 4. Bipolar Disorder Market Restraints
    Table 5. Global Bipolar Disorder Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bipolar Disorder Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Bipolar Disorder Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Bipolar Disorder Product Type
    Table 9. Key Companies Time to Begin Mass Production of Bipolar Disorder
    Table 10. Global Bipolar Disorder Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Bipolar Disorder Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Bipolar Disorder Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Bipolar Disorder Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Bipolar Disorder Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Bipolar Disorder Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Bipolar Disorder Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Bipolar Disorder Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Bipolar Disorder Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Bipolar Disorder Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Bipolar Disorder Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Bipolar Disorder Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Bipolar Disorder Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Bipolar Disorder Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Bipolar Disorder Sales Value by Region (2019-2024) & (%)
    Table 27. Global Bipolar Disorder Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Bipolar Disorder Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Bipolar Disorder Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Bipolar Disorder Sales Value, (2025-2030) & (US$ Million)
    Table 31. Glaxo SmithKline (GSK) Basic Information List
    Table 32. Glaxo SmithKline (GSK) Description and Business Overview
    Table 33. Glaxo SmithKline (GSK) Bipolar Disorder Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Bipolar Disorder Business of Glaxo SmithKline (GSK) (2019-2024)
    Table 35. Glaxo SmithKline (GSK) Recent Developments
    Table 36. Pfizer Inc. Basic Information List
    Table 37. Pfizer Inc. Description and Business Overview
    Table 38. Pfizer Inc. Bipolar Disorder Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Bipolar Disorder Business of Pfizer Inc. (2019-2024)
    Table 40. Pfizer Inc. Recent Developments
    Table 41. Janssen Pharmaceuticals Basic Information List
    Table 42. Janssen Pharmaceuticals Description and Business Overview
    Table 43. Janssen Pharmaceuticals Bipolar Disorder Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Bipolar Disorder Business of Janssen Pharmaceuticals (2019-2024)
    Table 45. Janssen Pharmaceuticals Recent Developments
    Table 46. Eli Lilly Basic Information List
    Table 47. Eli Lilly Description and Business Overview
    Table 48. Eli Lilly Bipolar Disorder Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Bipolar Disorder Business of Eli Lilly (2019-2024)
    Table 50. Eli Lilly Recent Developments
    Table 51. Allergan Plc. Basic Information List
    Table 52. Allergan Plc. Description and Business Overview
    Table 53. Allergan Plc. Bipolar Disorder Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Bipolar Disorder Business of Allergan Plc. (2019-2024)
    Table 55. Allergan Plc. Recent Developments
    Table 56. Novartis AG Basic Information List
    Table 57. Novartis AG Description and Business Overview
    Table 58. Novartis AG Bipolar Disorder Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Bipolar Disorder Business of Novartis AG (2019-2024)
    Table 60. Novartis AG Recent Developments
    Table 61. AbbVie Inc. Basic Information List
    Table 62. AbbVie Inc. Description and Business Overview
    Table 63. AbbVie Inc. Bipolar Disorder Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Bipolar Disorder Business of AbbVie Inc. (2019-2024)
    Table 65. AbbVie Inc. Recent Developments
    Table 66. Otsuka Holdings Ltd Basic Information List
    Table 67. Otsuka Holdings Ltd Description and Business Overview
    Table 68. Otsuka Holdings Ltd Bipolar Disorder Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Bipolar Disorder Business of Otsuka Holdings Ltd (2019-2024)
    Table 70. Otsuka Holdings Ltd Recent Developments
    Table 71. AstraZeneca Basic Information List
    Table 72. AstraZeneca Description and Business Overview
    Table 73. AstraZeneca Bipolar Disorder Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Bipolar Disorder Business of AstraZeneca (2019-2024)
    Table 75. AstraZeneca Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Bipolar Disorder Downstream Customers
    Table 79. Bipolar Disorder Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Bipolar Disorder Product Picture
    Figure 2. Global Bipolar Disorder Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bipolar Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 4. Bipolar Disorder Report Years Considered
    Figure 5. Global Bipolar Disorder Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Bipolar Disorder Revenue in 2023
    Figure 7. Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Bipolar I Disorder Picture
    Figure 9. Bipolar II Disorder Picture
    Figure 10. Cyclothymic Disorder Picture
    Figure 11. Global Bipolar Disorder Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Bipolar Disorder Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Mood Stabilizers
    Figure 14. Product Picture of Anticonvulsants
    Figure 15. Product Picture of Antipsychotic drugs
    Figure 16. Product Picture of Antidepressant drugs
    Figure 17. Product Picture of Antianxiety drugs
    Figure 18. Product Picture of Others
    Figure 19. Global Bipolar Disorder Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Bipolar Disorder Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Bipolar Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Bipolar Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Bipolar Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Bipolar Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Bipolar Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Bipolar Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Bipolar Disorder Sales Value (%), (2019-2030)
    Figure 32. United States Bipolar Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Bipolar Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Bipolar Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Bipolar Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Bipolar Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Bipolar Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Bipolar Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Bipolar Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Bipolar Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Bipolar Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Bipolar Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Bipolar Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Bipolar Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Bipolar Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Bipolar Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 53. Bipolar Disorder Industrial Chain
    Figure 54. Bipolar Disorder Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation

Bipolar disorder (formerly called manic-depressive illness or manic depression) is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks.

The global market for Bipolar Disorder was estimated to be worth US$ 5781 million in 2023 and is forecast to a readjusted size of US$ 6994.7 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030

North American market for Bipolar Disorder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bipolar Disorder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Bipolar Disorder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Bipolar Disorder include Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Ltd and AstraZeneca, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bipolar Disorder, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bipolar Disorder by region & country, by Type, and by Application.

The Bipolar Disorder market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bipolar Disorder.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bipolar Disorder manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Bipolar Disorder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Bipolar Disorder in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.